The choice ahead
If your clinician has offered you a choice between semaglutide and tirzepatide, you are looking at two different medications that work on appetite in different ways. Both are injected once a week. Both reduce how much you eat and how often you think about food. But they are not identical, and understanding the difference matters when you are committing to a treatment over months or years.
This post walks through how each one works, what the clinical data shows, and what side effects tend to look like with each. The goal is to give you enough grounding to have a real conversation with your clinician about which one might fit your body and your life.
How semaglutide works
Semaglutide is a GLP-1 receptor agonist. That means it mimics a hormone your gut naturally makes when you eat. GLP-1 tells your brain you are full, slows down how fast your stomach empties, and reduces cravings.
The medication acts on one pathway. It does not burn fat or boost your metabolism. It changes the signal that tells you to keep eating. For many people, that signal is loud and constant; semaglutide turns down the volume.
You inject it under the skin once a week. The dose starts low and increases gradually over several weeks, a process called titration. Most people reach a maintenance dose between 1.7 and 2.4 mg per week.
How tirzepatide works
Tirzepatide is a dual agonist. It activates two receptors: GLP-1 and GIP. GIP is another hormone that regulates appetite and blood sugar. By hitting both pathways at once, tirzepatide creates a stronger signal to your brain that you are satisfied.
Think of semaglutide as turning down the appetite dial. Tirzepatide turns it down further by engaging a second mechanism. The clinical trials suggest this dual action produces a larger reduction in appetite for some people.
Tirzepatide is the active ingredient in Mounjaro (for type 2 diabetes) and Zepbound (for weight management). Like semaglutide, it is injected once weekly and titrated gradually. Maintenance doses typically range from 10 to 15 mg per week.
Efficacy: what the data shows
Clinical trials show that tirzepatide tends to produce a larger average reduction in body weight than semaglutide over the same timeframe. In the trials, tirzepatide users lost around 20 to 22 percent of body weight over roughly 72 weeks, while semaglutide users lost around 15 to 17 percent over similar periods.
That is an average. Some people on semaglutide lose more than the average. Some on tirzepatide lose less. Your own result depends on your metabolism, how strictly you follow the dietary changes the medication enables, and how your body responds to the specific mechanism.
- Semaglutide: GLP-1 pathway only; established track record over many years
- Tirzepatide: dual GLP-1 and GIP pathways; newer, with larger average weight loss in trials
- Both: require ongoing injections and lifestyle support to sustain results
Neither medication works if you stop taking it. Appetite returns when the medication leaves your system. The weight loss is real while you are on it, but it is not permanent without continued use or lasting habit change.
Side effects and tolerability
Both medications slow gastric emptying, the rate at which food moves from your stomach to your intestines. This is how they reduce hunger. It also means nausea, constipation, and changes to digestion are common in the first weeks.
Semaglutide side effects
Nausea is the most frequent complaint, especially during titration. It usually improves as your body adjusts. Constipation, reduced appetite for foods you normally enjoy, and mild fatigue are typical. Serious side effects are rare but include pancreatitis and gallbladder issues; these require immediate medical attention.
Tirzepatide side effects
Because tirzepatide engages two pathways, gastrointestinal side effects, nausea, vomiting, diarrhea, constipation, tend to be more pronounced, especially early on. Some people tolerate it well; others find the digestive disruption harder to manage than with semaglutide. Serious side effects mirror those of semaglutide.
Neither medication is appropriate for many people after assessment. People with a personal or family history of thyroid cancer, multiple endocrine neoplasia, or severe pancreatitis should not take these drugs. A clinician here will review your full medical history before prescribing.
- Start low and increase slowly to let your body adjust
- Nausea often peaks in weeks 2 to 4, then improves
- Staying hydrated and eating smaller portions helps
- Report severe or persistent symptoms to your clinician immediately
Cost and insurance coverage
Both semaglutide and tirzepatide are expensive. A month's supply costs roughly $900 to $1,300 per month without insurance, though pricing depends on pharmacy and whether you use a brand or compounded version.
Commercial insurance coverage varies widely. Most plans require prior authorisation and may impose step therapy, meaning you try and fail on a cheaper medication first. Medicare Part D has historically excluded weight-loss drugs, though this landscape is evolving.
At a clinic in Austin, we work with your insurance to understand what is covered. Some patients find compounded versions more affordable; others prefer brand-name formulations. Your clinician will discuss options during your assessment.
Which one is right for you
There is no universal answer. Your clinician will consider your medical history, other medications you take, how your body has responded to weight-loss treatments in the past, and your tolerance for potential side effects.
- Semaglutide may be preferred if you have a history of severe nausea or gastrointestinal sensitivity, or if you want to start with a medication with a longer clinical track record
- Tirzepatide may be preferred if you are seeking a larger average weight loss and can tolerate more pronounced early side effects
- Your insurance coverage may influence the choice; some plans cover one but not the other without prior authorisation
- Dosing and titration schedules differ slightly; your clinician will explain the timeline for your specific medication
The best medication is the one you will actually take consistently and that your body tolerates well enough to stick with. A clinician here can help you weigh these factors during a consultation.
Common questions
Can I switch from semaglutide to tirzepatide later?
Yes. Some people start on one and switch to the other if they are not seeing results or if side effects are too severe. The switch typically happens after a washout period of a few days. Your clinician will guide the transition.
Do these medications work for type 2 diabetes and weight loss?
Yes. Semaglutide and tirzepatide both lower blood sugar and support weight loss. If you have type 2 diabetes, the medication addresses both conditions. The dosing and indication may differ from weight-management-only use.
What happens when I stop taking the medication?
Appetite returns as the medication leaves your system. Weight regain is common if you return to old eating patterns. Long-term success depends on the habits you build while on the medication, portion control, protein intake, and regular movement.
Are there drug interactions I should know about?
Both medications can interact with certain diabetes drugs and some other prescriptions. A full review of your medication list is part of the assessment. Read more about drug interactions to prepare for your consultation.
How long does titration take?
Typically 4 to 8 weeks, depending on how your body tolerates each dose increase. Your clinician will adjust the pace based on side effects and your response. Learn more about dosing and titration schedules.
Next steps
If you are ready to explore which medication might work for you, start with a consultation. A clinician will review your health history, discuss your weight-loss goals, and explain how each medication works in your specific situation. Learn more about eligibility requirements and our medical weight loss program.
You can also read more about how GLP-1 medications work and common side effects to prepare for your first appointment.